"The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Multiple myeloma is a form of blood cancer that p"...
Prevention of Chemotherapy-Induced Nausea and Vomiting
ALOXI (palonosetron hydrochloride) is indicated for:
DOSAGE AND ADMINISTRATION
Dosage for Adults - a single 0.25 mg I.V. dose administered over 30 seconds. Dosing should occur approximately 30 minutes before the start of chemotherapy
Instructions for Administration
ALOXI (palonosetron hydrochloride) is supplied ready for intravenous injection. ALOXI (palonosetron hydrochloride) should not be mixed with other drugs. Flush the infusion line with normal saline before and after administration of ALOXI (palonosetron hydrochloride) .
Parenteral drug products should be inspected visually for particulate matter and discoloration before administration, whenever solution and container permit.
Dosage Form And Strengths
ALOXI (palonosetron hydrochloride) is supplied as a single-use sterile, clear, colorless solution in glass vials that provides 0.25 mg (free base) per 5 mL.
HOW SUPPLIED/STORAGE AND HANDLING
NDC # 58063-797-25, 0.25 mg/5 mL (free base) single-use vial individually packaged in a carton
- Store at controlled temperature of 20-25°C (68°F-77°F). Excursions permitted to 15-30 °C (59-86°F).
- Protect from freezing.
- Protect from light.
Mfd by: Cardinal Health, Albuquerque, NM, USA or Pierre Fabre,
Médicament Production, Idron, Aquitaine, France and Helsinn Birex Pharmaceuticals,
HELSINN, Mfd for Helsinn Healthcare SA, Switzerland
MGI PHARMA, INC. Distributed and marketed by MGI PHARMA, INC. Bloomington, MN. 55437 under license of Helsinn Healthcare SA, Switzerland. FDA rev date: 8/30/2007
Last reviewed on RxList: 9/27/2007
This monograph has been modified to include the generic and brand name in many instances.
Additional Aloxi Information
Aloxi - User Reviews
Aloxi User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.